These alternatives demonstrate superior safety profiles and patient satisfaction compared to IV administration
GLP-1R agonists may exert antidepressant effects by modulating inflammatory processes in the brain Chronic inflammatory processes in the brain associated with excessive activation of microglia and increased production of pro-inflammatory cytokines are one of the key factors leading to the development of depressive symptoms, as patients suffering from this mental illness are very often characterized by elevated levels of tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), interleukin-1 beta (IL-1), C-reactive protein (CRP), and interferon-gamma (IFN-) in the cerebrospinal fluid and the blood [59,60,61]
Discussion In the present study, we found that GLP-1R protein levels decreased significantly in a knee OA rat model induced by monoiodoacetate, which was accompanied by the downregulation of the PKA/CREB pathway and upregulation of the inflammation-related proteins TNF-, IL-6 and IL-1
"Malignant Peripheral Nerve Sheath TumorsA Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management"
With rising obesity rates, increasing diabetes prevalence, and improved affordability, GLP-1 therapies are witnessing unprecedented adoption across India